other material
confidence high
sentiment positive
materiality 0.45
Amphastar Board authorizes $50M increase to share buyback program
Amphastar Pharmaceuticals, Inc.
- Board authorized $50M increase to buyback program on March 12, 2026.
- Program has indefinite duration; primary goal is offsetting dilution from equity compensation.
- Purchases may be via open market, block trades, Rule 10b5-1 plans, or private transactions.
- Timing and number of shares depend on price, regulatory requirements, and other conditions.